Datum ex-dividendy společnosti Albireo Pharma Inc
Jaká je hodnota metriky Datum ex-dividendy společnosti Albireo Pharma Inc?
Hodnota metriky Datum ex-dividendy společnosti Albireo Pharma Inc je N/A
Jaká je definice metriky Datum ex-dividendy?
Datum ex-dividendy (Ex-dividend date) je datem, který určuje, zda budou dividendy vyplacené prodejci nebo kupujícímu.Vyplacené dividendy za akcie koupené po datu ex-dividend patří novému majiteli.
The ex-dividend date or reinvestment date is an investment term involving the timing of payment of dividends on stocks of corporations, income trusts, and other financial holdings. If a sale is before this date, the dividend belongs to the new owner; if on or after the date, the seller is entitled to the dividend. If a stock is purchased on its ex-dividend date or after, the buyer will not receive the next dividend payment. Instead, the seller gets the dividend. If a stock is purchased before the ex-dividend date, the buyer gets the dividend.
Čemu se věnuje společnost Albireo Pharma Inc?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.